Nano Dimension Announces Record Q1/2023 Results Revenue of $14.97 Million, 43% YoY Growth

In this article:
Nano Dimension Ltd.Nano Dimension Ltd.
Nano Dimension Ltd.

Gross Margins increased to 44% (Adjusted: 47%)

Best Quarter in the Company’s History

50% Organic Revenue Growth since Q3/2022

Company Plans to Continue its Share Buy-Back Program

Conference Call to be Held Today at 9:00 a.m. EDT

Waltham, Massachusetts, June 29, 2023 (GLOBE NEWSWIRE) --  Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, today announced financial results for the first quarter ended March 31st, 2023.

The Company also announced the intention to promptly continue its share buy-back program.

Nano Dimension reported consolidated record revenues of $14.97 million for Q1/2023, an increase of:

  • 43% over Q1/2022

  • 24% over Q4/2022

Gross Margin (“GM”):

  • Q1/2023: 44%

  • Q1/2022: 10%

Adjusted1 Gross Margin (“Adjusted GM”):

  • Q1/2023: 47%

  • Q1/2022: 40%

Total income/loss before tax:

  • Q1/2023 income of $22 million

  • Q4/2022: negative $87 million

  • Q1/2022: negative $34 million

Adjusted EBITDA for the Q1/2023:

Negative $24 million which includes research and development (R&D) expenses of $15 million2.

Net cash used in operations; minus interest received:

  • Q1/2023: $17 million

  • Q4/2022: $14 million

  • Q1/2022: $21 million

Details regarding Adjusted EBITDA and Adjusted GM can be found below in this press release under “non-IFRS measures.”

CEO MESSAGE TO SHAREHOLDERS:

“We delivered significant revenue growth in the first quarter of 2023, with the third record-setting quarter in a row, defined by exceptional performance and steady quarterly organic growth since July 2022. While we still have 6 months left to go in 2023, at this point we hope to be ahead of the annual budget which our Board of Directors has set for us.

One of the most exciting developments this quarter is the fast adoption of our Deep Learning/AI technology, developed by our DeepCube division. It is now effectively installed in our newer models of machines, advancing industrial inspection, print quality optimization, process optimization, and monitoring and maintenance of machines.

While DeepCube is a significant value-add to new and existing customers, we are starting to receive requests from industrial customers to sell them the “DeepCube AI Engine” by itself, to be installed on their own machines, thereby turning our DeepCube group into a “stand-alone” revenue generating division.

Our Additive Electronic business has been growing organically for almost a year, in spite of the continued crisis in the European economy, especially in the DACH countries. Our AME printing business is advancing on budget, supported by impressive achievements in chemical development of dielectric and conductive printing consumable materials. In parallel, IPC International, Inc. (IPC), a global association that helps original equipment manufacturers, Electronics Manufacturing services, printed circuit board manufacturers, and suppliers build electronics better, has accepted our efforts of over a year – and is now adopting new standards for AME specifications. In the Additive Manufacturing and Ink Services product lines we are experiencing steady advancements as well.

Our organic growth is expected to be fully supported by our merger and acquisition (M&A) strategy. Consistent with our stated long-term strategy, strong market position, and robust balance sheet, we remain ideally positioned to act as a consolidator in the highly fragmented AM market landscape, which consists of small- and medium-sized businesses that are currently cash negative and “floating” on high valuations. We intend to accelerate our M&A strategy by carefully investing in assets that will create return on investment and value expansion for our shareholders, contrary to unprofitability which is still a common denominator for many players in the AM industry.”

Please feel free to read our new website regarding Nano’s special tender offer to purchase ordinary shares of Stratasys and educate yourselves: www.stratasysvaluenow.com

For information on how to tender Stratasys shares, call Georgeson LLC, the information agent for the special tender offer, toll-free at (877) 668-1646.
  
FINANCIAL RESULTS:

First Quarter 2023 Financial Results

  • Total revenues for the first quarter of 2023 were $14,965,000, compared to $12,104,000 in the fourth quarter of 2022, and $10,430,000 in the first quarter of 2022. The increase is attributed to increased sales of the Company’s product lines.

  • R&D expenses for the first quarter of 2023 were $19,250,000, compared to $20,993,000 in the fourth quarter of 2022, and $17,870,000 in the first quarter of 2022. The decrease compared to the fourth quarter of 2022 is mainly attributed to a decrease in materials expenses and payroll and related expenses. The increase compared to the first quarter of 2022 is mainly attributed to an increase in payroll expenses, material, subcontractors, and depreciation expenses and is partially offset by a decrease in share-based compensation expenses.

  • Sales and marketing expenses for the first quarter of 2023 were $7,486,000, compared to $9,758,000 in the fourth quarter of 2022, and $9,308,000 in the first quarter of 2022. The decrease is mainly attributed to a decrease in share-based compensation and marketing expenses.

  • General and administrative expenses for the first quarter of 2023 were $11,033,000, compared to $9,091,000 in the fourth quarter of 2022, and $6,742,000 in the first quarter of 2022. The increase is mainly attributed to an increase in payroll and related expenses, share-based compensation expenses, and professional services.

  • Net income for the first quarter of 2023 was $22,222,000, or $0.09 per share, compared to net loss of $87,667,000, or $0.34 loss per share, in the fourth quarter of 2022, and net loss of $33,093,000, or $0.13 loss per share, in the first quarter of 2022.

Conference call information

The Company will host a conference call to discuss these financial results today, June 29th, 2023, at 9:00 a.m. EDT (4:00 p.m. IDT).

We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10179970/f9b871241c.

Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=p8t1ENcZ.

U.S. Dial-in Number: 844-695-5517, INTERNATIONAL DIAL IN: 1-412-902-6751, Israel Dial-in Number: 1-80-9212373. Please request the “Nano Dimension NNDM call” when prompted by the conference call operator. For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at http://investors.nano-di.com/events-and-presentations.

About Nano Dimension

Nano Dimension’s (Nasdaq: NNDM) vision is to transform existing electronics and mechanical manufacturing into Industry 4.0 environmentally friendly & economically efficient precision additive electronics and manufacturing – by delivering solutions that convert digital designs to electronic or mechanical devices - on demand, anytime, anywhere.
  
Nano Dimension’s strategy is driven by the application of deep learning-based AI to drive improvements in manufacturing capabilities by using self-learning & self-improving systems, along with the management of a distributed manufacturing network via the cloud.

Nano Dimension serves over 2,000 customers across vertical target markets such as aerospace & defense, advanced automotive, high-tech industrial, specialty medical technology, R&D and academia. The company designs and makes Additive Electronics and Additive Manufacturing 3D printing machines and consumable materials. Additive Electronics are manufacturing machines that enable the design and development of High-Performance-Electronic-Devices (Hi-PED®s). Additive Manufacturing includes manufacturing solutions for production of metal, ceramic, and specialty polymers-based applications - from millimeters to several centimeters in size with micron precision.

Through the integration of its portfolio of products, Nano Dimension is offering the advantages of rapid prototyping, high-mix-low-volume production, IP security, minimal environmental footprint, and design-for-manufacturing capabilities, which is all unleashed with the limitless possibilities of additive manufacturing. For more information, please visit www.nano-di.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Nano Dimension’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Nano Dimension could differ materially from those described in or implied by the statements in this press release. For example, Nano Dimension is using forward-looking statements when it discusses its expectations for revenues for 2023, the advantages and benefits of its products and technology, growth of AE business and advancement of AME printing business, that its organic growth in the year ahead is expected to be fully supported by its M&A strategy and its intention to lead its M&A by carefully paying for assets that will create return on investment and value expansion for its shareholders and its expectation to continue the share buyback program. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano Dimension’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 30, 2023, and in any subsequent filings with the SEC. Except as otherwise required by law, Nano Dimension undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Nano Dimension is not responsible for the contents of third-party websites.

NANO DIMENSION INVESTOR RELATIONS CONTACT

Investor Relations | ir@nano-di.com

Unaudited Consolidated Statements of Financial Position as at

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2023

 

 

20223

 

(In thousands of USD)

 

(Unaudited)

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

788,141

 

 

 

412,172

 

 

 

685,362

 

Bank deposits

 

 

459,824

 

 

 

573,847

 

 

 

346,663

 

Restricted deposits

 

 

126

 

 

 

60

 

 

 

60

 

Trade receivables

 

 

6,242

 

 

 

10,152

 

 

 

6,342

 

Other receivables

 

 

7,307

 

 

 

6,076

 

 

 

6,491

 

Inventory

 

 

15,063

 

 

 

20,040

 

 

 

19,400

 

Total current assets

 

 

1,276,703

 

 

 

1,022,347

 

 

 

1,064,318

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted deposits

 

 

491

 

 

 

1,107

 

 

 

850

 

Bank deposits

 

 

63,128

 

 

 

 

 

 

 

Investment in securities

 

 

 

 

 

160,260

 

 

 

114,984

 

Deferred tax

 

 

1,005

 

 

 

118

 

 

 

115

 

Other receivables

 

 

 

 

 

816

 

 

 

809

 

Property plant and equipment, net

 

 

9,844

 

 

 

10,012

 

 

 

5,843

 

Right-of-use assets

 

 

15,142

 

 

 

15,497

 

 

 

16,539

 

Intangible assets

 

 

21,358

 

 

 

 

 

 

 

Total non-current assets

 

 

110,968

 

 

 

187,810

 

 

 

139,140

 

Total assets

 

 

1,387,671

 

 

 

1,210,157

 

 

 

1,203,458

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Trade payables

 

 

3,785

 

 

 

5,503

 

 

 

3,722

 

Financial derivatives and deferred consideration

 

 

19,977

 

 

 

5,040

 

 

 

8,798

 

Other payables

 

 

19,304

 

 

 

23,180

 

 

 

24,150

 

Current portion of other long-term liability

 

 

416

 

 

 

347

 

 

 

363

 

Total current liabilities

 

 

43,482

 

 

 

34,070

 

 

 

37,033

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liability in respect of government grants

 

 

1,639

 

 

 

1,861

 

 

 

1,492

 

Employee benefits

 

 

4,138

 

 

 

1,561

 

 

 

1,462

 

Liability in respect of warrants

 

 

1,760

 

 

 

123

 

 

 

69

 

Lease liability

 

 

12,395

 

 

 

11,409

 

 

 

12,374

 

Deferred tax liabilities

 

 

1,101

 

 

 

 

 

 

 

Other long-term liabilities

 

 

1,849

 

 

 

 

 

 

 

Loan from banks

 

 

 

 

 

686

 

 

 

736

 

Total non-current liabilities

 

 

22,882

 

 

 

15,640

 

 

 

16,133

 

Total liabilities

 

 

66,364

 

 

 

49,710

 

 

 

53,166

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

Non-controlling interests

 

 

787

 

 

 

578

 

 

 

767

 

Share capital

 

 

386,723

 

 

 

389,943

 

 

 

388,406

 

Share premium and capital reserves

 

 

1,276,443

 

 

 

1,300,781

 

 

 

1,296,194

 

Treasury shares

 

 

(1,509

)

 

 

(19,901

)

 

 

(1,509

)

Foreign currency translation reserve

 

 

1,190

 

 

 

973

 

 

 

583

 

Remeasurement of net defined benefit liability (IAS 19)

 

 

 

 

 

2,508

 

 

 

2,508

 

Accumulated loss

 

 

(342,327

)

 

 

(514,435

)

 

 

(536,657

)

Equity attributable to owners of the Company

 

 

1,320,520

 

 

 

1,159,869

 

 

 

1,149,525

 

Total equity

 

 

1,321,307

 

 

 

1,160,447

 

 

 

1,150,292

 

Total liabilities and equity

 

 

1,387,671

 

 

 

1,210,157

 

 

 

1,203,458

 

  

Unaudited Consolidated Statements of Profit or Loss and Other Comprehensive Income

 

 

Three Months Ended
March 31,

 

 

Year ended
December 31,

 

 

 

2022

 

 

2023

 

 

2022

 

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

 

USD

 

 

USD

 

 

USD

 

Revenues

 

 

10,430

 

 

 

14,965

 

 

 

43,633

 

Cost of revenues

 

 

6,580

 

 

 

8,267

 

 

 

24,943

 

Cost of revenues - write-down of inventories and impairment of assets recognized in business combination and technology

 

 

2,849

 

 

 

132

 

 

 

4,639

 

Total cost of revenues

 

 

9,429

 

 

 

8,399

 

 

 

29,582

 

Gross profit

 

 

1,001

 

 

 

6,566

 

 

 

14,051

 

Research and development expenses, net

 

 

17,870

 

 

 

19,250

 

 

 

75,763

 

Sales and marketing expenses

 

 

9,308

 

 

 

7,486

 

 

 

38,833

 

General and administrative expenses

 

 

6,742

 

 

 

11,033

 

 

 

30,457

 

Impairment losses on intangible assets

 

 

 

 

 

 

 

 

40,523

 

Operating loss

 

 

(32,919

)

 

 

(31,203

)

 

 

(171,525

)

Finance income

 

 

2,861

 

 

 

56,826

 

 

 

22,965

 

Finance expense

 

 

3,685

 

 

 

3,590

 

 

 

79,471

 

Income (Loss) before taxes on income

 

 

(33,743

)

 

 

22,033

 

 

 

(228,031

)

Taxes benefit (expense)

 

 

455

 

 

 

(74

)

 

 

(264

)

Income (Loss) for the period

 

 

(33,288

)

 

 

21,959

 

 

 

(228,295

)

Income (Loss) attributable to non-controlling interests

 

 

(195

)

 

 

(263

)

 

 

(872

)

Income (Loss) attributable to owners

 

 

(33,093

)

 

 

22,222

 

 

 

(227,423

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share

 

 

(0.13

)

 

 

0.09

 

 

 

(0.88

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation differences for foreign operations

 

 

(232

)

 

 

403

 

 

 

(844

)

Other comprehensive income items that will not be transferred to profit or loss

 

 

 

 

 

 

 

 

 

 

 

 

Remeasurement of net defined benefit liability (IAS 19), net of tax

 

 

 

 

 

 

 

 

2,508

 

Total other comprehensive income (loss) for the period

 

 

(232

)

 

 

403

 

 

 

1,664

 

Total comprehensive income (loss) for the period

 

 

(33,520

)

 

 

22,362

 

 

 

(226,631

)

Comprehensive loss attributable to non-controlling interests

 

 

(210

)

 

 

(250

)

 

 

(892

)

Comprehensive income (loss) attributable to owners of the Company

 

 

(33,310

)

 

 

22,612

 

 

 

(225,739

)


Consolidated Statements of Changes in Equity (Unaudited)
(In thousands of USD)

 

 

Share capital

 

 

Share premium and capital reserves

 

 

Remeasurement of IAS 19

 

 

Treasury shares

 

 

Presentation / Foreign currency translation reserve

 

 

Accumulated loss

 

 

Total

 

 

Non-controlling interests

 

 

Total equity

 

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

Thousands

 

 

 

USD

 

 

USD

 

 

USD

 

 

USD

 

 

USD

 

 

USD

 

 

USD

 

 

USD

 

 

USD

 

Balance as of December 31, 2022

 

 

388,406

 

 

 

1,296,194

 

 

 

2,508

 

 

 

(1,509

)

 

 

583

 

 

 

(536,657

)

 

 

1,149,525

 

 

 

767

 

 

 

1,150,292

 

Investment of non-controlling party in subsidiary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61

 

 

 

61

 

Income for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22,222

 

 

 

22,222

 

 

 

(263

)

 

 

21,959

 

Other comprehensive income for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

390

 

 

 

 

 

 

390

 

 

 

13

 

 

 

403

 

Exercise of warrants, options and conversion of convertible notes

 

 

1,537

 

 

 

(1,537

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchase of treasury shares

 

 

 

 

 

 

 

 

 

 

 

(18,392

)

 

 

 

 

 

 

 

 

(18,392

)

 

 

 

 

 

(18,392

)

Share-based Compensation

 

 

 

 

 

6,124

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,124

 

 

 

 

 

 

6,124

 

Balance as of March 31, 2023

 

 

389,943

 

 

 

1,300,781

 

 

 

2,508

 

 

 

(19,901

)

 

 

973

 

 

 

(514,435

)

 

 

1,159,869

 

 

 

578

 

 

 

1,160,447

 

  

Consolidated Statements of Cash Flows (Unaudited)
(In thousands of USD)

 

 

Three Months Ended
March 31,

 

 

Year ended
December 31

 

 

 

2022

 

 

2023

 

 

2022

 

Cash flow from operating activities:

 

 

 

 

 

 

 

 

 

Net income (loss)

 

 

(33,288

)

 

 

21,959

 

 

 

(228,295

)

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,141

 

 

 

1,423

 

 

 

7,283

 

Impairment losses on intangible assets

 

 

 

 

 

 

 

 

31,045

 

Impairment losses on property plant and equipment

 

 

 

 

 

 

 

 

9,478

 

Financing (income) expenses, net

 

 

2,194

 

 

 

(8,152

)

 

 

(1,769

)

Revaluation of financial liabilities accounted at fair value

 

 

(1,370

)

 

 

191

 

 

 

(4,516

)

Revaluation of financial assets accounted at fair value

 

 

 

 

 

(45,276

)

 

 

62,791

 

Loss from disposal of property plant and equipment and ROU Assets

 

 

(3

)

 

 

124

 

 

 

948

 

Increase in deferred tax

 

 

(461

)

 

 

(3

)

 

 

(581

)

Share-based compensation

 

 

10,123

 

 

 

6,124

 

 

 

32,563

 

Other

 

 

94

 

 

 

45

 

 

 

166

 

 

 

 

11,718

 

 

 

(45,524

)

 

 

137,408

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Increase in inventory

 

 

(468

)

 

 

(545

)

 

 

(4,603

)

Increase in other receivables

 

 

(851

)

 

 

(851

)

 

 

(1,978

)

Increase in trade receivables

 

 

(2,175

)

 

 

(3,708

)

 

 

(1,992

)

Increase in other payables

 

 

1,724

 

 

 

(528

)

 

 

5,281

 

Increase (decrease) in employee benefits

 

 

1,148

 

 

 

(561

)

 

 

1,497

 

Increase in trade payables

 

 

729

 

 

 

1,805

 

 

 

628

 

 

 

 

107

 

 

 

(4,388

)

 

 

(1,167

)

Net cash used in operating activities

 

 

(21,463

)

 

 

(27,953

)

 

 

(92,054

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Change in bank deposits and loans net

 

 

(21,907

)

 

 

(228,497

)

 

 

141,555

 

Interest received

 

 

762

 

 

 

11,292

 

 

 

17,465

 

Change in restricted bank deposits

 

 

20

 

 

 

(271

)

 

 

(327

)

Acquisition of property plant and equipment

 

 

(1,975

)

 

 

(3,944

)

 

 

(9,388

)

Acquisition of subsidiaries, net of cash acquired

 

 

(18,124

)

 

 

 

 

 

(31,057

)

Payment of a liability to pay a contingent consideration of business combination

 

 

 

 

 

(3,960

)

 

 

(10,708

)

Acquisition of financial assets in fair value through profit and loss

 

 

 

 

 

 

 

 

(177,775

)

Decrease in pledged deposit

 

 

 

 

 

 

 

 

3,362

 

Other

 

 

 

 

 

 

 

 

(800

)

Net cash used in investing activities

 

 

(41,224

)

 

 

(225,380

)

 

 

(67,673

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Lease payments

 

 

(796

)

 

 

(1,220

)

 

 

(4,151

)

Repayment Long-term Bank Debt

 

 

(80

)

 

 

(57

)

 

 

(406

)

Proceeds from non-controlling interests

 

 

 

 

 

 

 

 

510

 

Amounts recognized in respect of government grants liability, net

 

 

(45

)

 

 

(85

)

 

 

(221

)

Payments of share price protection recognized in business combination

 

 

 

 

 

 

 

 

(1,005

)

Repurchase of treasury shares

 

 

 

 

 

(18,392

)

 

 

 

Net cash provided by (used in) financing activities

 

 

(921

)

 

 

(19,754

)

 

 

(5,273

)

Decrease in cash

 

 

(63,608

)

 

 

(273,087

)

 

 

(165,000

)

Cash at beginning of the year

 

 

853,626

 

 

 

685,362

 

 

 

853,626

 

Effect of exchange rate fluctuations on cash

 

 

(1,877

)

 

 

(103

)

 

 

(3,264

)

Cash at end of the period

 

 

788,141

 

 

 

412,172

 

 

 

685,362

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash transactions:

 

 

 

 

 

 

 

 

 

 

 

 

Property plant and equipment acquired on credit

 

 

211

 

 

 

476

 

 

 

52

 

Recognition of a right-of-use asset

 

 

11,237

 

 

 

127

 

 

 

15,196

 

 

Non-IFRS measures

The following are reconciliations of income before taxes, as calculated in accordance with International Financial Reporting Standards (“IFRS”), to EBITDA and Adjusted EBITDA, as well as of gross profit, as calculated in accordance with IFRS, to Adjusted Gross Profit:

 

 

For the Three-Month Period
Ended March 31st, 2023

 

 

 

 

 

Net income

 

 

21,959

 

Tax expenses

 

 

74

 

Depreciation and amortization

 

 

1,423

 

Interest income

 

 

(11,520

)

EBITDA

 

 

11,936

 

Finance income from revaluation of assets and liabilities

 

 

(44,777

)

Exchange rate differences

 

 

3,045

 

Share-based compensation expenses

 

 

6,124

 

Adjusted EBITDA (loss)

 

 

(23,672

)


 

 

For the Three-Month
Period Ended

 

 

 

March 31,

 

 

 

2022

 

 

2023

 

Gross profit

 

 

1,001

 

 

 

6,566

 

Depreciation and amortization4

 

 

2,862

 

 

 

66

 

Share-based compensation expenses

 

 

324

 

 

 

422

 

Adjusted gross profit

 

 

4,187

 

 

 

7,054

 

EBITDA is a non-IFRS measure and is defined as income before taxes, excluding depreciation and amortization expenses and amortization of assets recognized in business combination and interest income. We believe that EBITDA, as described above, should be considered in evaluating the Company’s operations. EBITDA facilitates the Company’s performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures, and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.

Adjusted EBITDA is a non-IFRS measure and is defined as income before taxes, excluding depreciation and amortization expenses and amortization of assets recognized in business combination, interest income, finance income for revaluation of assets and liabilities, exchange rate differences and share-based payments. We believe that Adjusted EBITDA, as described above, should also be considered in evaluating the Company’s operations. Like EBITDA, Adjusted EBITDA facilitates the Company’s performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures, and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from revaluation of assets and liabilities, exchange rate differences and share-based payment expenses. Adjusted EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to non-cash items, such as expenses related to revaluation, exchange rate differences and share-based payments.

Adjusted gross profit, excluding depreciation and amortization and share-based compensation expenses, is a non-IFRS measure and is defined as gross profit excluding amortization expenses. We believe that adjusted gross profit, as described above, should also be considered in evaluating the Company’s operations. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company’s performance without regard to non-cash items, such as amortization expenses. Adjusted gross margin is calculated by dividing the adjusted gross profit by the revenues.

EBITDA, Adjusted EBITDA, and Adjusted gross profit do not represent cash generated by operating activities in accordance with IFRS and should not be considered alternatives to net income (loss) as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) as presented in our consolidated statements of profit or loss and other comprehensive income. Other companies may calculate these measures differently than we do.

 

 

1 Excluding cost of revenues from depreciation and amortization and share-based compensation expenses

2 Excluding share-based compensation expenses and depreciation

3 The December 31, 2022 balances were derived from the Company’s audited annual financial statements

4 Including amortization of assets recognized in business combination and technology


Advertisement